相关实验视频
Updated: May 8, 2025

07:27
Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
21.9K
阿尔法-同核素病理和与帕金森病相关的嗅觉功能障碍:临床前模型和治疗方法的更新
Jancy Nixon Abraham1,2, Devesh Rawat3, Priyadharshini Srikanth3
1Laboratory of Neural Circuits and Behaviour (LNCB), Department of Biology, Indian Institute of Science Education and Research (IISER), Pune, Maharashtra, 411008, India. jancysara@gmail.com.
概括
嗅觉功能障碍 (OD) 是帕金森病 (PD) 的早期征兆,可能会因COVID-19而恶化. 了解与PD相关的OD中的α-synuclein (α-syn) 对于开发新疗法至关重要.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 病理学 病理学 病理学
背景情况:
- 嗅觉功能障碍 (OD) 影响超过90%的帕金森病 (PD) 患者,通常是运动症状的先驱.
- OD是PD的潜在早期生物标志物,COVID-19可能会加剧OD的神经退行性疾病.
- 尽管在PD病变发生过程中发现了α-synuclein (α-syn),但其在OD中的作用仍然不清楚.
研究的目的:
- 审查神经元死亡中α-synuclein聚合的机制.
- 讨论最近PD临床前模型的发展,展示OD.
- 探索目前和潜在的PD治疗策略.
主要方法:
- 在帕金森病中对α-synuclein病原体的文献综述.
- 对带有嗅觉功能障碍的帕金森病临床前模型的分析.
- 对帕金森病当前治疗方法的综合分析.
主要成果:
- α-synuclein聚合与帕金森病中的神经元死亡有关.
- 临床前模型正在推进对PD中OD的理解.
- 目前PD的治疗方法包括药物治疗,深度大脑刺激和免疫治疗.
结论:
- 精确监测嗅觉功能对于早期PD检测和管理至关重要.
- 需要进一步研究OD中的α-synuclein病原体.
- 开发可靠的PD模型对于治疗进步至关重要.
相关概念视频
Parkinson's Disease: Overview
306
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
306
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Alzheimer's Disease: Overview
313
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
313

